Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1998-02-24
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 544283, 544284, 544287, 544293, A61K 31505, C07D40304, C07D23502
Patent
active
057212376
ABSTRACT:
This invention relates to a method for the selective treatment of cell growth and differentiation characterized by activity of the human epidermal growth factor receptor type 2 (HER2). More specifically, this invention relates to the use of substituted or unsubstituted mono- or bi-cyclic aryl, heteroaryl, cycloalkyl or heterocycloalkyl compounds in selectively regulating cell growth. Pharmaceutical compositions useful for the selective treatment of cell growth and differentiation are also described.
REFERENCES:
patent: 3715358 (1973-02-01), Witzel et al.
patent: 3718743 (1973-02-01), Shen et al.
patent: 3985749 (1976-10-01), Foster
patent: 4322420 (1982-03-01), Kobayashi et al.
patent: 4464375 (1984-08-01), Kobayashi et al.
patent: 4465686 (1984-08-01), Lesher et al.
patent: 4599423 (1986-07-01), Lesher et al.
patent: 4661499 (1987-04-01), Young et al.
patent: 5646153 (1997-07-01), Spada et al.
Tetrahedron, vol. 38, No. 22, pp. 3347-3354 (1982), Tamao et al.
Synthesis, pp. 564-565 (Jul. 1986), Yamamoto et al.
Chem. Pharm. Bull., vol. 30, No. 6, pp. 2003-2010 (1982), Yamamoto et al.
Heterocycles, vol. 23, No. 9, pp. 2375-2386 (1985), Ishikura et al.
J. Am. Chem. Soc., vol. 111, No. 3, pp. 877-891 (1989), Stern et al.
Chemical Abstract, vol. 84:164632t, p. 453 (1976), Yoshida.
Chemical Abstracts, vol. 103:123292z, p. 709 (1985), Barker et al.
Chemical Abstract, vol. 108:55860j, p. 704 (1988), Epling.
Beilstein-Band EIII/IV 21, p. 2436 (1978).
J.Heterocyclic Chem., vol. 20, pp. 1739-1740 (1983), Saeed et al.
Maguire Martin P.
Myers Michael R.
Persons Paul E.
Spada Alfred P.
Nicholson James A.
Parker III Raymond S.
Raymond Richard L.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
LandOfFree
Protein tyrosine kinase aryl and heteroaryl quinazoline compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein tyrosine kinase aryl and heteroaryl quinazoline compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein tyrosine kinase aryl and heteroaryl quinazoline compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875355